Croda International PLC (LON:CRDA) Rating Reaffirmed
The firm has just set a target price per share of GBX 2830.00 on Croda International PLC (LON:CRDA) shares. This is -0.25% from the last stock close price. In recent note made public on 4 December, Liberum Capital maintained their Hold rating on shares of CRDA.
From a total of 17 analysts covering Croda International PLC (LON:CRDA) stock, 6 rate it a ”Buy”, 2 a “Sell”, and 9 a ”Hold”. This means that 35% of the ratings are positive. The highest target price is GBX 3400 while the lowest target price is GBX 1800. The mean of all analyst targets is GBX 2958.65 with a 6.09% above today’s (GBX 2843) stock price. Croda International PLC was the topic of 37 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Deutsche Bank maintained shares on December 3 with “Buy” rating. BNP Paribas maintained shares with “Neutral” rating and GBX 2880 target share price in a report from a December 1. Societe Generale maintained CRDA stock in a recent report from December 2 with “Buy” rating. Goldman Sachs maintained the rating on November 30. Goldman Sachs has a “Buy” rating and a GBX 3400 price target on shares. Finally, Morgan Stanley maintained the stock with “Overwt/In-Line” rating in a report issued on a December 1.
Approximately 8,288 shares of stock traded hands. Croda International Plc (LON:CRDA) has risen 2.91% since May 7, 2015 and is uptrending. It has outperformed by 5.70% the S&P500.
Croda International Plc is a United Kingdom specialty chemical manufacturer. The company has a market cap of 3.86 billion GBP. The Company’s divisions include Personal Care, Life Sciences, Performance Technologies and Industrial Chemicals. It has 22.1 P/E ratio. The Firm is a supplier of specialty ingredients for the personal care industry.